A novel hybrid high speed mass spectrometer allows rapid translation from biomarker candidates to targeted clinical tests using 15N labeled proteins
M. Wahle, P. Remes, V. Albrecht, J. B. Mueller-Reif, S. Steigerwald, T. Heymann, L. Niu, P. Loessl, S. Horning, C. Jacob, M. Mann
The paper introduces a novel hybrid mass spectrometer, Stellar MS, enabling rapid and sensitive clinical biomarker validation using 15N labeled proteins.
bioRxiv · Jun 2, 2024Biochemistry